The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 03, 2017
Filed:
Mar. 05, 2014
Applicants:
Medarex, L.l.c., Princeton, NJ (US);
Amgen Inc., Thousand Oaks, CA (US);
Inventors:
Brian Varnum, Santa Monica, CA (US);
Chris Vezina, Newbury Park, CA (US);
Alison Witte, Scotts Valley, CA (US);
Xueming Qian, Oaks Park, CA (US);
Francis Hall Martin, Newbury Park, CA (US);
Haichun Huang, Fremont, CA (US);
Gary Elliott, Thousand Oaks, CA (US);
Assignees:
Amgen Inc., Thousand Oaks, CA (US);
E.R. Squibb & Sons, L.L.C., Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract
Antibodies that interact with interleukin-1 receptor type 1 (IL-1R1) are described. Methods of treating IL-1 mediated diseases by administering a pharmaceutically effective amount of antibodies to IL-1R1 are described. Methods of detecting the amount of IL-1R1 in a sample using antibodies to IL-1R1 are described.